Haijun Deng

8.7k total citations · 2 hit papers
61 papers, 2.8k citations indexed

About

Haijun Deng is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Haijun Deng has authored 61 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Epidemiology and 13 papers in Infectious Diseases. Recurrent topics in Haijun Deng's work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Haijun Deng is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Haijun Deng collaborates with scholars based in China, Malaysia and Thailand. Haijun Deng's co-authors include Ailong Huang, Quanxin Long, Jieli Hu, Juan Chen, Jun Yuan, Kun Su, Qin Li, Wei Xü, Bo Wu and Jingfu Qiu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Haijun Deng

52 papers receiving 2.7k citations

Hit Papers

Clinical and immunological assessment of asymptomatic SAR... 2020 2026 2022 2024 2020 2023 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haijun Deng China 16 1.8k 564 413 349 293 61 2.8k
Yongxiang Yi China 20 1.7k 0.9× 579 1.0× 316 0.8× 338 1.0× 278 0.9× 49 2.8k
Jieli Hu China 17 1.8k 1.0× 482 0.9× 406 1.0× 346 1.0× 512 1.7× 54 2.8k
Zhang Qi China 19 1.0k 0.6× 605 1.1× 346 0.8× 122 0.3× 257 0.9× 82 2.3k
Pin Yü China 18 1.4k 0.8× 417 0.7× 354 0.9× 115 0.3× 260 0.9× 38 2.2k
Fuxiang Wang China 11 1.4k 0.8× 471 0.8× 528 1.3× 181 0.5× 216 0.7× 29 2.3k
Jie Sheng China 16 1.4k 0.7× 622 1.1× 223 0.5× 110 0.3× 98 0.3× 41 2.2k
Sin‐Yee Fung Hong Kong 13 1.4k 0.8× 493 0.9× 302 0.7× 165 0.5× 155 0.5× 21 2.1k
Yong Feng China 20 1.5k 0.8× 703 1.2× 549 1.3× 54 0.2× 249 0.8× 63 2.5k
Josephine L. Barnes United Kingdom 9 1.2k 0.6× 506 0.9× 500 1.2× 68 0.2× 342 1.2× 10 2.2k
Zichun Xiang China 17 2.7k 1.4× 834 1.5× 424 1.0× 83 0.2× 607 2.1× 28 3.7k

Countries citing papers authored by Haijun Deng

Since Specialization
Citations

This map shows the geographic impact of Haijun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijun Deng more than expected).

Fields of papers citing papers by Haijun Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haijun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijun Deng. The network helps show where Haijun Deng may publish in the future.

Co-authorship network of co-authors of Haijun Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Haijun Deng. A scholar is included among the top collaborators of Haijun Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haijun Deng. Haijun Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Minli, Sheng‐Tao Cheng, Huiying Gu, et al.. (2025). RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma. Advanced Science. 12(38). e01373–e01373.
2.
Deng, Haijun, et al.. (2025). Fed, not fasted: is carbohydrate mouth rinsing still ergogenic? A three-level meta-analysis. Journal of the International Society of Sports Nutrition. 22(1). 2579027–2579027.
3.
4.
Huang, Ailong, et al.. (2024). Detection of HBV DNA integration in plasma cell-free DNA of different HBV diseases utilizing DNA capture strategy. Virologica Sinica. 39(4). 655–666. 3 indexed citations
5.
Yu, Haibo, Haijun Deng, Zhenzhen Zhang, et al.. (2024). Neuropilin-1 is a novel host factor modulating the entry of hepatitis B virus. Journal of Hepatology. 82(1). 37–50. 13 indexed citations
6.
Tang, Yuting, Ting Wang, Hongli Ji, et al.. (2023). Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer. iScience. 26(7). 107116–107116. 13 indexed citations
7.
Nie, Dan, Xin Tang, Haijun Deng, et al.. (2023). Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre‐mRNA Splicing as a Noncanonical Mechanism to Suppress Hepatocellular Carcinoma Metastasis. Advanced Science. 11(5). e2305374–e2305374. 13 indexed citations
8.
Liu, Rui, Haijun Deng, Chang Chen, et al.. (2023). Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression. Journal of Clinical Investigation. 133(13). 40 indexed citations
9.
Li, Xiaosong, Haijun Deng, Qian Yang, et al.. (2023). Real-world effectiveness of an intranasal spray A8G6 antibody cocktail in the post-exposure prophylaxis of COVID-19. Signal Transduction and Targeted Therapy. 8(1). 403–403. 5 indexed citations
10.
Du, Jianlin, Xin Yuan, Haijun Deng, et al.. (2023). Single-cell and spatial heterogeneity landscapes of mature epicardial cells. Journal of Pharmaceutical Analysis. 13(8). 894–907. 19 indexed citations
11.
Liu, Yi, Guiji Zhang, Haijun Deng, et al.. (2023). Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice. Nature Communications. 14(1). 1402–1402. 90 indexed citations breakdown →
13.
Li, Jie, Jinlan Wang, Wenlu Zhang, et al.. (2022). Protein sensors combining both on-and-off model for antibody homogeneous assay. Biosensors and Bioelectronics. 209. 114226–114226. 7 indexed citations
14.
Wang, Zhuo, et al.. (2021). Quantification of intrahepatic cccDNA in HBV associated hepatocellular carcinoma by improved ddPCR method. Journal of Virological Methods. 299. 114334–114334. 6 indexed citations
15.
Jin, Xiang, Chang Chen, Rui Liu, et al.. (2021). Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. Journal of Clinical Investigation. 131(8). 85 indexed citations
16.
Xiao, Nan, Meng Nie, Huanhuan Pang, et al.. (2021). Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nature Communications. 12(1). 1618–1618. 180 indexed citations
17.
Deng, Haijun, Jie Hu, Jianjiang Xue, et al.. (2021). Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine. Cell Discovery. 7(1). 68–68. 8 indexed citations
18.
Wang, Kai, Quanxin Long, Haijun Deng, et al.. (2020). Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Clinical Infectious Diseases. 73(3). e531–e539. 130 indexed citations
19.
Long, Quanxin, Qin Li, Haijun Deng, et al.. (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine. 26(8). 1200–1204. 1695 indexed citations breakdown →
20.
Deng, Haijun, et al.. (2015). Lower Mutation Frequency of BCP/Precore Regions in e Antigen-Negative Chronic HBV-Infected Children instead of Adults Patients. PLoS ONE. 10(3). e0120733–e0120733. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026